Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
226. Hill VA, Whittaker SJ, Hunt BJ, et al. Cutaneous necrosis associated with the antiphos-pholipid syndrome and mycosis fungoides. Br J Dermatol 1994; 130: 92—96.
227. Doff HJ, Sarkany I, OShaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985; 10: 581—586.
228. Wattiaux H-J, Herve R, Robert A, Cabane J, Housset B, Imbert J-C. Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome. Arthritis Rheum 1994; 37: 1096—1100.
229. Asherson RA, Jacobelli S, Rosenberg H, et al. Skin nodules and macules resembling vasculi-tis in the antiphospholipid syndrome. Clin Exp Dermatol 1992; 17: 166—169.
230. Renfro L, Franks AG, Grudberg M, Kamino H. Painful nodules in a young female — Antiphospholipid syndrome. (Technical Note). Arch Dermat 1992; 128: 847.
231. Asherson RA. Subungual splinter haemorrhages: a new sign of the antiphospholipid coagu-lopathy?Ann Rheum Dis 1990; 49: 268.
232. Frances C, Piette J, Saada V, et. al. Multiple subungual splinter haemorrhages in the antiphospholipid syndrome. A report of 5 cases and review of the literature. Lupus 1994; 30: 123—128.
233. Kleiner RC, Najarian IV, Schatten S, et al. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989; 96: 896— 904.
234. Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 228—232.
235. Carbone J, Sanchez-Ramon S, Cobo-Soriano R, et al. Antiphospholipid antibodies: A risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. J Rheumatol 2001; 28: 2437.
236. Liote F, Meyer O, Osteoarticular manifestations in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette J-C, Shoenfeld Y (Eds). The antiphospholipid syndrome. CRC Press. Boca Raton 1996; 195—200.
237. Klippel TM, Stevens MB, Zizic TM, Hungerford DS. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 1976; 55: 251—257.
238. Glueck CJ, Freiberg R, Glueck HE, et al. Hypofibrinolisis: a common, major cause of osteonecrosis. Am J Mematol 1994; 45: 156— 166.
239. Asherson RA, Jungers P, Liot F, et al. Ischaemic necrosis of bone associated with the "lupus anticoagulant" and antibodies to cardi-olipin. Proceedings of the XVIth International Congress of Rheumatology. Sydney, Australia. 1983; 373.
240. Asherson RA, Liot F, Page B, et al. Avas-cular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993; 20: 284—288.
241. Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardi-olipin antibodies. J Rheumatol 1991; 18:1416— 1417.
242. Alijotas J, Argem M, Barquinero J. Kienbock's disease and antiphospholipid antibodies. Clin Exp Rheumatol 1990; 8 297—298.
SHS-OOO4.qxd 21.11.2006 16:56 Page 2 05
05
ГЛАВА 7. Клинические проявления антифосфолипидного синдрома
243. Picillo U, Migliaresi S, Marciolis MR, Longobardo A, La Palombara F, Tirri G. Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationship with clinical manifestations and disease activity in an Italian series. Scand J Rheumatol 1992; 21: 271—276.
244. Petri M. Musculoskeletal complication of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 1995; 18: 137—145.
245. Houissau FA, NZeusseu-Toukap A, Depresseu XG, et al. Magnetic resonance imag-ing-detected, avascular necrosis in systemic lupus erythematosus: lack of correlation with antiphos-pholipid antibodies. Br J Rheumatol 1998; 37: 448—453.
246. Nagasawa K, Ishii Y, Mayumi T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48: 672— 676.
247. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654—662.
248. Jones LC, Mont MA, Lr TB, et al. Proco-agulants and osteonecrosis. J Rheumatology 2003; 30: 783—791.
249. Tektonidou MG, Malagari K, Vlachoyian-nopoulos PG, et al. Asympomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use. Arthritis Rheum 2003; 48: 732—736.
250. Lockwood CJ, Schur PH. Clinical manifestations and diagnosis of the antiphospholipid antibody syndrome in pregnancy. UpToDate 2002; 11.1.
251. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. N Engl J Med 1991; 325: 1063.
252. Oshiro BT, Silver RM, Scott JR, et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489.
253. Hornstein MD, Davis OK, Massey JB, et al. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 2000; 73: 330.
254. Vivaldi P, Rossetti G, Galli M, Finazzi G. Severe bleeding due to acquired hypoprothrom-binemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica 1997; 82: 345.
